Honorable Senfronia Thompson, Chair, House Committee on Public Health
FROM:
John McGeady, Assistant Director Sarah Keyton, Assistant Director Legislative Budget Board
IN RE:
HB1849 by Klick (Relating to the possession and administration of epinephrine auto-injectors in day-care centers; limiting liability. ), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
The bill would create a new authorization and establish requirements for a physician, or a person delegated prescriptive authority, to prescribe epinephrine auto-injectors to specified day-care centers.
The bill would require day-care centers to report certain information relating to the administration of auto-injectors. Day-care centers would report to the Health and Human Services Commission (HHSC), the Department of State Health Services (DSHS), the owner of the day care, and the prescribing entity.
The Texas Medical Board (TMB), HHSC, DSHS, and the Texas Board of Pharmacy do not anticipate a significant fiscal impact from the provisions of the bill. TMB indicates that it could receive complaints relating to prescribing and physician supervision of and delegation to providers, but it is unlikely there would be a significant number of these complaints. According to DSHS, the bill would require the agency to update an electronic form, assist HHSC in developing rules, and educate stakeholders of bill requirements. DSHS indicates it could absorb the costs associated with the bill within its current resources.
The bill would take effect immediately if it receives a vote of two-thirds of all the members elected to each house. If the bill does not receive the vote necessary for immediate effect, the bill would take effect September 1, 2019.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies:
529 Health and Human Services Commission, 537 State Health Services, Department of